Adamczyk joined Goldman Sachs in 2024 as advisory chairman of private investments and operations following a 16-year stint at ...

Shares lift as CSL, banks rise; Trump mulls tariff relief for autos; UBS’ healthcare picks; Star unveils earnings; Bellevue ...

European stocks rose on Monday after the Trump administration exempted some tech products from the so-called reciprocal tariffs. The exemptions for tech-related products will likely provide short-term ...

Normally, in the struggles between markets and Governments, the former tend to win. Politicians' reaction to these crises follows the famous pattern ...

Explore the Goldman Sachs Apple Card and discover how it redefines your credit card experience with innovation and ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Amid rising market panic and economic uncertainty, US President Donald Trump abruptly paused his newly imposed tariffs on ...

Donald Trump’s pledge to pause tariffs on some trading partners ignited the biggest burst of buying Wall Street has seen ...

Goldman Sachs economists have revised their S&P 500 targets, aligning with other Wall Street forecasters. They currently characterize the selloff as an event-driven bear market, noting its ...

Apple (AAPL) has multiple, significant, positive catalysts, Goldman Sachs Managing Director Sung Cho told CNBC recently. He noted that AAPL stock is his largest holding in the tech sector.

Fintel reports that on April 8, 2025, Goldman Sachs downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to Neutral. Analyst Price Forecast Suggests 14.83% Upside As of April 1 ...

Goldman Sachs says Brent oil could fall under $40 by 2026 in an 'extreme' scenario US oil production may suffer as prices near breakeven costs, risking modest growth. Oil prices could slump to ...